Folinic acid + 5-fluorouracil (5-FU) versus equidose 5-FU in advanced colorectal cancer. Phase III study of 'GISCAD' (Italian Group for the Study of Digestive Tract Cancer).

R Labianca; G Pancera; E Aitini; S Barni; A Beretta; G D Beretta; B Cesana; G Comella; L Cozzaglio; M Cristoni

doi:10.1093/oxfordjournals.annonc.a058047

Folinic acid + 5-fluorouracil (5-FU) versus equidose 5-FU in advanced colorectal cancer. Phase III study of 'GISCAD' (Italian Group for the Study of Digestive Tract Cancer).

Identifier:nobleid.org/w1/20260515/809EACB3

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/809EACB3.svg?ark=w1%2F20260515%2F809EACB3)](https://nobleid.org/work/w1/20260515/809EACB3)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Folinic acid + 5-fluorouracil (5-FU) versus equidose 5-FU in advanced colorectal cancer. Phase III study of 'GISCAD' (Italian Group for the Study of Digestive Tract Cancer).

Identifier:nobleid.org/w1/20260515/809EACB3

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/809EACB3.svg?ark=w1%2F20260515%2F809EACB3)](https://nobleid.org/work/w1/20260515/809EACB3)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work